ArticleFrontiers in cardiovascular medicine2026
Machine learning-based identification of heart failure with reduced ejection fraction using routine laboratory indicators.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early recognition of heart failure with reduced ejection fraction (HFrEF) is clinically important because treatment pathways and prognosis differ across left ventricular ejection fraction phenotypes. When echocardiography is delayed, routinely available laboratory data may help prioritize patients for definitive imaging. Methods: This single-center retrospective study included 1,480 hospitalized patients with chronic heart failure, comprising 377 with HFrEF and 1,103 with HFmrEF/HFpEF. Baseline laboratory indicators were obtained from the first blood draw within 24 h of admission, and matched echocardiography was typically performed within 48 h. After a stratified 7:3 train-test split, preprocessing, imputation, standardization, feature selection, and model training were conducted within a leakage-free machine-learning pipeline. Cross-validated recursive feature elimination retained 13 routine indicators: proBNP, HCT, TBil, DBil, BUN, Results: The HFrEF group showed higher proBNP, BUN, TBil, DBil, GGT, HCT, and UA levels than the HFmrEF/HFpEF group. In the independent test set, random forest and XGBoost achieved the highest AUCs (both 0.789), whereas logistic regression showed comparable discrimination (AUC: 0.784) and strong calibration (intercept 0.017; slope 1.069). Random forest had the lowest Brier score (0.152), but pairwise bootstrap comparisons showed no statistically significant AUC differences among models. At the default threshold, sensitivity was limited; however, moving the random forest threshold to 0.15 increased sensitivity to 0.912 and negative predictive value to 0.935, supporting a rule-out triage strategy for prioritized echocardiography. SHAP analysis identified proBNP as the dominant predictor, followed by HCT, DBil, Glb, UA, GGT, TBil, and LDL-C. Conclusions: A 13-indicator routine laboratory model provided moderate discrimination for distinguishing HFrEF from HFmrEF/HFpEF. Random forest had the numerically most favorable balance of discrimination and calibration, but its clinical usefulness depends on threshold optimization rather than default classification. The model should be regarded as an adjunctive triage tool pending external and prospective validation, not as a substitute for echocardiographic phenotyping.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.